©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessMenke-Hennekam syndrome 1; Rubinstein-Taybi syndrome 1

Summary

Short information

A comprehensive panel containing 2 core genes and altogether 8 curated genes for the differential diagnosis of Rubinstein-Taybi syndrome

ID
RP0170
Number of genes
8 Accredited laboratory test
Examined sequence length
14,6 kb (Core-/Core-canditate-Genes)
35,6 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
CREBBP7329NM_004380.3AD
EP3007245NM_001429.4AD
FGFR12469NM_023110.3AD
FGFR22466NM_000141.5AD
GLI34743NM_000168.6AD
HOXD131032NM_000523.4AD
SRCAP9693NM_006662.3AD
TWIST1609NM_000474.4AD

Informations about the disease

Clinical Comment

Rubinstein-Taybi Syndrome is a disease characterized by short stature, moderate to severe mental retardation, distinct facial features and broad thumbs/toes. Other variable characteristics include eye, heart and kidney malformations, dental problems and obesity. These patients also have an increased risk of developing benign skin and brain tumors. In addition to causing Rubinstein-Taybi syndrome, pathogenic germline variants of the CREBBP and EP300 genes are also associated with Menke-Hennekam syndrome by missense mutations in exon 30 or 31 of CREBBP or the homologous regions of the EP300 gene, respectively. However, individuals with Menke-Hennekam syndrome do not have typical facial features or broad/angled thumbs. Rubinstein-Taybi syndrome is inherited autosomal dominantly, but typically occurs as a result of a new mutation. If the parents are not clinically affected, a mild phenotype of one parent may be present or a somatic and/or germline mosaic may be observed. The empirical recurrence risk for siblings is otherwise à priori <1%. The DNA-diagnostic yield is above 70%. An inconspicuous genetic finding therefore does not exclude a suspected clinical diagnosis.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK1526/

 

Synonyms
  • Alias: Broad thumbs-hallux syndrome + mental retardation
  • Allelic: Bent bone dysplasia syndrome (FGFR2)
  • Allelic: Brachydactyly, type D (HOXD13)
  • Allelic: Colorectal cancer, somatic (EP300)
  • Allelic: Craniofacial-skeletal-dermatologic dysplasia (FGFR2)
  • Allelic: Craniosynostosis 1 (TWIST1)
  • Allelic: Craniosynostosis, nonspecific (FGFR2)
  • Allelic: Encephalocraniocutaneous lipomatosis, somatic mosaic (FGFR1)
  • Allelic: Hypogonadotropic hypogonadism 2 with/-out anosmia (FGFR1)
  • Allelic: Menke-Hennekam syndrome 1 (CREBBP)
  • Allelic: Menke-Hennekam syndrome 2 (EP300)
  • Allelic: Polydactyly, postaxial, types A1 + B (GLI3)
  • Allelic: Polydactyly, preaxial, type IV (GLI3)
  • Allelic: Scaphocephaly and Axenfeld-Rieger anomaly (FGFR2)
  • Allelic: Scaphocephaly, maxillary retrusion + mental retardation (FGFR2)
  • Allelic: Syndactyly, type V (HOXD13)
  • Allelic: Synpolydactyly 1 (HOXD13)
  • Allelic: Trigonocephaly 1 (FGFR1)
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
  • Apert syndrome (FGFR2)
  • Beare-Stevenson cutis gyrata syndrome (FGFR2)
  • Brachydactyly, type E (HOXD13)
  • Brachydactyly-syndactyly syndrome (HOXD13)
  • Crouzon syndrome (FGFR2)
  • Floating-Harbor syndrome (SRCAP)
  • Greig cephalopolysyndactyly syndrome (GLI3)
  • Hartsfield syndrome (FGFR1)
  • Jackson-Weiss syndrome (FGFR1, FGFR2)
  • LADD syndrome (FGFR2)(FGFR2)
  • Osteoglophonic dysplasia (FGFR1)
  • Pallister-Hall syndrome (GLI3)
  • Pfeiffer syndrome (FGFR1, FGFR2)
  • Robinow-Sorauf syndrome (TWIST1)
  • Rubinstein-Taybi syndrome 1 (CREBBP)
  • Rubinstein-Taybi syndrome 2 (EP300)
  • Saethre-Chotzen syndrome (FGFR2)
  • Saethre-Chotzen syndrome with/-out eyelid anomalies (TWIST1)
  • Sweeney-Cox syndrome (TWIST1)
Heredity, heredity patterns etc.
  • AD
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined